Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared With Cabacitaxel in Costa Rica, in Patients with Metastatic Castration-Resistant Prostate Cancer That Have Failed to Chemotherapy with Docetaxel
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2278
https://www.valueinhealthjournal.com/article/S1098-3015(14)04208-9/fulltext
Title :
Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared With Cabacitaxel in Costa Rica, in Patients with Metastatic Castration-Resistant Prostate Cancer That Have Failed to Chemotherapy with Docetaxel
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04208-9&doi=10.1016/j.jval.2014.08.2278
First page :
A635
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1738